The China transmucosal drug delivery systems market is expected to reach US$ 24,518.6 Mn in 2027 from US$ 9,520.3 Mn in 2018. The market is estimated to grow with a CAGR of 11.2% from 2019-2027.
Rising prevalence of various chronic diseases such as respiratory, gastrointestinal, and autoimmune diseases are expected to surge the market growth. Moreover, the advantages offered by transmucosal route of administration increasing its adaptability is also responsible for boosting the market growth over the years. However, high cost of production of drug delivery devices under stringent regulatory observation is likely to have a negative impact on the growth of the market in the coming years.
The development of alternative methods for drug administration has improved the ability of physicians to manage various medical obstacles. One of the promising alternative to traditional drug delivery techniques is the transmucosal route. Drug absorption through a mucosal surface is generally efficient as the major absorption barrier across the skin known as stratum corneum epidermidis is absent in the mucous layers. These surfaces thus are abundant in blood supply thereby facilitating rapid drug transport to the systemic circulation and avoiding the degradation by first-pass hepatic metabolism. Oro-mucosal delivery, especially that utilizing the buccal and sublingual mucosa as absorption site, is a promising drug delivery route which promotes rapid absorption and high bioavailability, with subsequent almost immediate onset of pharmacological effect. Moreover, the patients are feasibly able to control the period of drug administration and terminate the same in case of emergencies through transmucosal routes. Moreover, the drug administration through these routes also avoid harsh enzymes and acids that are encountered during digestion. In addition, the use of this route for drug delivery does not require a technical equipment and can be easily used by a common person making it feasible and a preferred choice. Hence, the collaborative advantages offered by transmucosal route of drug delivery is expected to drive the growth of the market in the coming years.
China transmucosal drug delivery systems market, based on route of administration was segmented into oral, vaginal, nasal, and urethral. In 2018, the oral segment held the largest share of the market, by route of administration. Moreover, the oral segment is also anticipated to grow at the highest rate during the forecast period as it is the most preferred and successfully investigated route of administration.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
CHINA TRANSMUCOSAL DRUG DELIVERY SYSTEMS – MARKET SEGMENTATION
By Route of Administration
- Oral
- Vaginal
- Nasal
- Urethral/Rectal
By Age Group
- Adults
- Pediatrics
By End User
- Hospitals
- Clinics
- Others
Companies Mentioned
- 3M
- Acrux Limited
- GW Pharmaceuticals plc
- INTELGENX CORP
- Mylan N.V.
- Novartis AG
- Reckitt Benckiser Group plc.
- Teva Pharmaceutical Industries Ltd
- UCB S.A.
- West Pharmaceutical Development, LLC

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Route of Administration, Age Group, End User

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Australia, China, Japan, South Korea
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
2. China Transmucosal Drug Delivery Systems Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. China Transmucosal Drug Delivery Systems Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 China PEST Analysis
4.3 Expert Opinions
4.4 Epidemiology Data
4.5 Regulatory Scenario for Methotryxate in China
4.6 Pricing Analysis
5. Transmucosal Drug Delivery Systems Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Rising Prevalence of Chronic Diseases
5.1.2 Advantages of Transmucosal Drug Delivery
5.2 Key Market Restraint
5.2.1 High Cost Involved in the Development of Drug Delivery Devices
5.3 Key Market Opportunity
5.3.1 Increasing Preference Towards Self-Administration and Home Care
5.4 Future Trend
5.4.1 Research and Development in Transmucosal Drug Delivery
5.5 Impact Analysis
6. China Transmucosal Drug Delivery Systems Market – China Market Analysis
6.1 Overview
6.2 China Transmucosal Drug Delivery Systems Market – Revenue Forecasts and Analysis – 2018- 2027
7. China Transmucosal Drug Delivery Systems Market Analysis– by Route of Administration
7.1 Overview
7.2 China Transmucosal Drug Delivery Systems Market, By Route of Administration 2018 & 2027 (%)
7.3 Oral Market
7.3.1 Overview
7.3.2 China Oral Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Vaginal Market
7.4.1 Overview
7.4.2 China Vaginal Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Nasal Market
7.5.1 Overview
7.5.2 China Nasal Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Urethral/Rectal Market
7.6.1 Overview
7.6.2 China Urethral/Rectal Market Revenue and Forecasts to 2027 (US$ Mn)
8. China Transmucosal Drug Delivery Systems Market Analysis– by Age Group
8.1 Overview
8.2 China Transmucosal Drug Delivery Systems Market, By Age Group 2018 & 2027 (%)
8.3 Adults Market
8.3.1 Overview
8.3.2 China Adults Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Pediatrics Market
8.4.1 Overview
8.4.2 China Pediatrics Market Revenue and Forecasts to 2027 (US$ Mn)
9. China Transmucosal Drug Delivery Systems Market Analysis– by End User
9.1.1 Overview
9.1.2 China Transmucosal Drug Delivery Systems Market, By End User 2018 & 2027 (%)
9.1.3 Hospitals Market
9.1.4 Overview
9.1.5 China Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6 Clinics Market
9.1.6.1 Overview
9.1.6.2 China Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7 Others Market
9.1.7.1 Overview
9.1.7.2 China Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. Transmucosal Drug Delivery Systems Market – Industry Landscape
10.1 Overview
10.2 Growth Strategies done by the companies in the Market, (%)
10.3 Organic Developments
10.3.1 Overview
10.4 Inorganic developments
10.4.1 Overview
11. Transmucosal Drug Delivery Systems Market–Key Company Profiles
11.1 3M
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Acrux Limited
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 GW Pharmaceuticals plc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Information
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 INTELGENX CORP
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Information
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Mylan N.V.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Novartis AG
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Information
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Reckitt Benckiser Group plc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Teva Pharmaceutical Industries Ltd
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 UCB S.A.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 West Pharmaceutical Services, Inc.
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Number of new cases in China (2018)
Table 2. Prevalence of Comorbidities in China
Table 3. Organic Developments Done By Companies
Table 4. Inorganic developments done by Companies
Table 5. Glossary of Terms, Transmucosal Drug Delivery Systems Market
LIST OF FIGURES
Figure 1. Transmucosal Drug Delivery Systems Market Segmentation
Figure 2. China Transmucosal Drug Delivery Systems Market Overview
Figure 3. Oral Segment Held Largest Share Of The Route of Administration Segment In Transmucosal Drug Delivery Systems Market
Figure 4. China Transmucosal Drug Delivery Systems Market, Industry Landscape
Figure 5. China PEST Analysis
Figure 6. Number of new cases China (2018)
Figure 7. Impact Analysis of Drivers and Restraint Pertaining to Transmucosal Drug Delivery Systems Market
Figure 8. China Transmucosal Drug Delivery Systems Market – Revenue Forecasts and Analysis – 2018- 2027
Figure 9. China Transmucosal Drug Delivery Systems Market, by Route of Administration 2018 & 2027 (%)
Figure 10. China Oral Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. China Vaginal Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. China Nasal Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. China Urethral/Rectal Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. China Transmucosal Drug Delivery Systems Market, by Age Group 2018 & 2027 (%)
Figure 15. China Adults Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. China Pediatrics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. China Transmucosal Drug Delivery Systems Market, by End User 2018 & 2027 (%)
Figure 18. China Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. China Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. China Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Growth Strategies done by the companies in the Market, (%)
The List of Companies
- 3M
- Acrux Limited
- GW Pharmaceuticals plc
- INTELGENX CORP
- Mylan N.V.
- Novartis AG
- Reckitt Benckiser Group plc.
- Teva Pharmaceutical Industries Ltd
- UCB S.A.
- West Pharmaceutical Development, LLC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.